Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early supraclavicular nerve grafting or distal nerve transfer for restoration of elbow flexion in incomplete adult traumatic brachial plexus injuries.

Brain & spine·2026
Same author

Visually-induced hemodynamic response and white matter hyperintensities in middle-aged women with ischemic stroke or migraine with aura.

Cephalalgia : an international journal of headache·2026
Same author

Longitudinal Extension of the Win Odds for Ordinal Repeated Measurements.

Statistics in medicine·2026
Same author

Results of Dynamic Decompression of the Lateral Femoral Cutaneous Nerve in Idiopathic Meralgia Paresthetica: A Case Series of 109 Procedures.

Neurosurgery·2026
Same author

Stimulating amyloid-β clearance in cerebral amyloid angiopathy with low-sodium oxybate and/or non-invasive vagus nerve stimulation (Clear-Brain): study protocol for a randomised pre-post trial.

BMJ open·2026
Same author

Refitting EuroSCORE II for 120-Day Mortality After Coronary Artery Bypass Grafting Using Nationwide Registry Data.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same journal

Laparoscopic-assisted myomectomy with uterine artery occlusion at a freestanding ambulatory surgery center: a case series.

Gynecological surgery·2020
Same journal

Laparoscopy in the coronavirus disease 2019 (COVID-19) era.

Gynecological surgery·2020
Same journal

Correction to: Cadaveric surgery in core gynaecology training: a feasibility study.

Gynecological surgery·2019
Same journal

Fetoscopic endoluminal tracheal occlusion and reestablishment of fetal airways for congenital diaphragmatic hernia.

Gynecological surgery·2018
Same journal

Surgical outcomes of laparoscopic hysterectomy with concomitant endometriosis without bowel or bladder dissection: a cohort analysis to define a case-mix variable.

Gynecological surgery·2018
Same journal

Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade.

Gynecological surgery·2018
See all related articles

Related Experiment Video

Updated: May 17, 2026

Inducing Pseudopregnancy in Female Mice Without the Need for Vasectomized Males Prior to Non-Surgical Embryo Transfer or Artificial Insemination
05:36

Inducing Pseudopregnancy in Female Mice Without the Need for Vasectomized Males Prior to Non-Surgical Embryo Transfer or Artificial Insemination

Published on: July 7, 2023

Ectopic pregnancy: when is expectant management safe?

Sharon P Rodrigues1, Kirsten J de Burlet, Ellen Hiemstra

  • 1Department of Gynecology, K6-76, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, the Netherlands.

Gynecological Surgery
|November 13, 2012
PubMed
Summary
This summary is machine-generated.

Expectant management for early ectopic pregnancy is effective for asymptomatic patients with initial serum beta-hCG levels below 2,500 IU/l. Higher initial levels do not improve success rates and may indicate a need for intervention.

Related Experiment Videos

Last Updated: May 17, 2026

Inducing Pseudopregnancy in Female Mice Without the Need for Vasectomized Males Prior to Non-Surgical Embryo Transfer or Artificial Insemination
05:36

Inducing Pseudopregnancy in Female Mice Without the Need for Vasectomized Males Prior to Non-Surgical Embryo Transfer or Artificial Insemination

Published on: July 7, 2023

Area of Science:

  • Gynecology
  • Reproductive Endocrinology
  • Obstetrics

Background:

  • Ectopic pregnancy (EP) diagnosis and management present clinical challenges.
  • Expectant management is a viable option for select EP cases.
  • Predicting successful expectant management requires understanding key biomarkers.

Purpose of the Study:

  • To evaluate expectant management in asymptomatic patients with initial serum beta-human chorionic gonadotropin (beta-hCG) titers <2,500 IU/l.
  • To determine the predictive ability of initial serum beta-hCG titers and their trend for successful expectant management.
  • To assess the optimal initial beta-hCG cutoff for expectant management in suspected EP.

Main Methods:

  • Retrospective cohort study of 418 patients with suspected EP (January 1991 - July 2008).
  • Patients categorized into immediate surgical intervention, unsuccessful expectant management, and successful expectant management groups.
  • Analysis of initial serum beta-hCG levels and their trends in relation to management outcomes.

Main Results:

  • Successful expectant management rate was 49% without increased complications.
  • Initial beta-hCG levels >3,000 IU/l were not associated with successful expectant management.
  • Expectant management was successful in 14% of asymptomatic patients with initial beta-hCG >2,000 IU/l, preventing unnecessary surgery.

Conclusions:

  • An initial serum beta-hCG cutoff of 2,000 IU/l is not absolute for expectant management in suspected EP; case specificity is key.
  • For asymptomatic patients, an initial serum beta-hCG cutoff of at least 2,500 IU/l can guide expectant management decisions.
  • Including patients with initial beta-hCG levels >3,000 IU/l for expectant management offers no benefit.